secwatch.observer — SEC 8-K summary
======================================

Issuer:     Context Therapeutics Inc. (CNTX)
CIK:        0001842952
Form:       8-K
Filed at:   2026-02-27T23:59:59+00:00
Accession:  0001628280-26-012813
Event type: litigation
Sentiment:  neutral
Materiality: 0.60
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Context Therapeutics settles governance lawsuit; annual director elections June 24, 2026
--------------------------------------------------------------------------------

- Stipulated consent judgment filed Feb 24 invalidates three-year director terms and for-cause removal from charter.
- Class action by Vladimir Gusinsky Revocable Trust will be dismissed with prejudice; charter corrected if court approves.
- Annual meeting set for June 24, 2026; record date April 27, 2026; agenda includes election of directors to one-year terms.
- Stockholder proposals and director nominations due by March 14, 2026; universal proxy notices due by April 13, 2026.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1842952/000162828026012813/0001628280-26-012813-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1842952/000162828026012813/cntx-20260224.htm
  HTML page:      https://secwatch.observer/filing/0001628280-26-012813

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer